Perol M., Caliandro R., Pommier P. [et al.]. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study // Ibid. – 1997. – Vol. III, No. 5. – P. 1417 – 1423.
Placenta G., Salio M., Betta P. Laser therapy and endobronchial stenting. Personal experience // Lung Cancer. Frontiers in Science and Treatment / Ed. G. Motta. – Genoa: Grafica L. P., 1994. – P. 273 – 281.
Roth J. A., Putnam J. B. New insights into selecting patients likely to benefit from resection of pulmonary metastases // Lung Cancer. Frontiers in Science and Treatment / Ed. G. Motta. – Genoa: Grafica L. P., 1994. – P. 473 – 482.
Rubinstein L., Ginsberg R. Lobectomy versus limited resection in Т1 NO lung cancer // Ann. Thorac. Surg. – 1996. – Vol. 62. – P. 1249.
Ruckdeschel J. C. Preoperative and postoperative adjuvant therapy for resectable NSCLC // Lung Cancer / Eds. J. A. Roth [et al.]. —2nd ed. – Blackwell Science, 1998. – P. 207 – 216.
Schinkel C., Dienemann H., Reinmii Hoffmann H. [et al.]. Regioi node involvement in non-small-cell bront cinoma // Chirurg, 1999, Vol. 70, No. 2. – Р. 179 – 183.
Schottenfeld D. Epidemiology of lung cancer // Lung Cancer. Principles and Practice / Eds.. H. I. Pass [et al.]. —Philadelphia. – N. – Y.: Lippincott-Raven, 1996. – P. 305 – 321.
Scott L. R., Müller N., Miller R. [et al.]. Resectable stage III lung cancer: CT, surgical and pathologic correlation // Radiology. – 1998. – Vol. 1. – P. 75 – 79. Sendus E., Lassem L, Karnicka-Modrowska V. [et al.]. Analysis of prognostic factory for long term survival in patients with SCLC // Pneumonol. Allergol. Pol. – 1994. – Vol. 62, No. 5 – 6. – P. 233 – 238.
Shure D. Tissue procurement; bronchoscopic techniques for lung cancer // Lung Cancer: Principles and Practice / Eds. H. I. Pass [et al.]. —Philadelphia: Lippicott-Raven, 1996. – P. 471 – 479.
Stout R. Endobronchial brachytherapy. The Manchester Experience using a single dose HDR – microselcctron technique // Lung Cancer Frontiers in Science and Treatment / Ed. G. Motta. – Genoa: Grafica L. P, 1994. – P. 295 – 300.
Sugi K., Nawata K., Fujita N. [et al.]. Systematic dissection for clinically diagnosed peripheral small-cell lung cancer less than 2 cm in World jornal of surgery, 1998. – Vol. 22, No. 3. – Р. 290 – 295.
Takita H., Merrin C., Didolkar M. S. [et al.]. The surgical management of multiple lung metastases // Ann. Thorac. Surg. – 1997. – Vol. 24. – P. 359 – 364.
Takizawa Т., Terashima M., Koike Т. H. [et al.]. Mediastinal metastasis in patients with clinical stage I peripheral Non-small – cell lung cancer // J. of Thoracic and Cardiovascular Surgery, 1997/ – Vol. 113, No. 2. Р. 248 – 252. IS: 222 – 223.
Takkouche В., Gestal– Otero J. J. The epidemiology of lung cancer: review of risk factors and Spanish data // int. J. Epidemiol. – 1996. – Vol. 12, No. 5. – P. 341 – 349.
Trachtenberg A. Kh., Frank G. A. Primary Malignant Non-Epithelial Tumors of the Lung: International Symposium of Thoracic Surgery. – M., 1996. – P. 101 – 107.
Travis W., Under J., Mackay B. Classification, histology, cytology and electron microscopy // Lung Cancer: Principles and Practice / Eds. H. Pass [et al.]. – Philadelphia – N. – Y.: Lipincott-Raven, 1996. – P. 361 – 395.
Vainio A., Auvinen A. [et al.]. Prevalence of symptoms among patients with advanced cancer. An International Collaborative Study // Pain Symptom Manage. – 1996. – Vol. 12, No. 1. – P. 3 – 10.
Van der Lee I., Smith E. F., van Putten J. [et al.]. Single-f gent gemcitabine in patients with resistant small-cell lung cancer. Ann Oncol. – 2001; Vol. 12. – P. 557 – 561.
